The MAIA trial represents the largest controlled investigation to date examining whether omega-3 polyunsaturated fatty acids can preserve functional independence in nursing home residents over 24 months. The study will track 432 elderly participants across multiple facilities, comparing those receiving omega-3 enriched diets against standard institutional meals, measuring independence through Activities of Daily Living scores alongside cognitive function, muscle strength, and inflammatory markers. This research addresses a critical gap in geriatric nutrition science. While omega-3s have shown promise in laboratory studies for reducing inflammation and supporting brain health, robust clinical evidence for preserving real-world functional independence in the most vulnerable elderly populations remains sparse. The nursing home setting is particularly challenging—residents face accelerated functional decline, malnutrition, and social isolation that may overwhelm any single nutritional intervention. The trial's 24-month duration and comprehensive outcome measures represent methodological strengths, though the open-label design and institutional clustering introduce potential confounding factors. If successful, this could reshape dietary standards across thousands of care facilities globally, potentially delaying the transition from assisted living to complete dependence for millions of elderly adults.